Search research articles
Contact Us
Filters
Showing results (1-10 of 6) with videos related to
Page
of 1
Sort By:
EJNMMI Research
|
September 28, 2017
Group-sequential analysis may allow for early trial termination: illustration by an intra-observer repeatability study
Oke Gerke, Mie H Vilstrup, Ulrich Halekoh, et al.
Diagnostics (Basel, Switzerland)
|
December 1, 2020
Interrater Agreement and Reliability of PERCIST and Visual Assessment When Using 18F-FDG-PET/CT for Response Monitoring of Metastatic Breast Cancer
Jonas S Sørensen, Mie H Vilstrup, Jorun Holm, et al.
European Journal of Nuclear Medicine and Molecular Imaging
|
February 7, 2022
The diagnostic accuracy and clinical impact of FDG-PET/CT follow-up for patients on adjuvant immunotherapy for high-risk malignant melanoma
Jesper A S Andersen, Anders D Spatzek, Mie H Vilstrup, et al.
Journal of Nuclear Cardiology : Official Publication of the American Society of Nuclear Cardiology
|
December 6, 2013
Delayed sodium 18F-fluoride PET/CT imaging does not improve quantification of vascular calcification metabolism: results from the CAMONA study
Björn A Blomberg, Anders Thomassen, Richard A P Takx, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
November 25, 2025
Primary Staging of Intermediate- and High-Risk Prostate Cancer Using [<sup>18</sup>F]PSMA-1007 PET/CT and [<sup>18</sup>F]NaF PET/CT: A Head-to-Head Comparison of Diagnostic Accuracy, Staging, and Patient Management
Karen M Buch-Olsen, Mie H Vilstrup, Steinbjørn Hansen, et al.
European Urology Open Science
|
June 8, 2026
Progression-free Survival Following Primary Staging with [<sup>18</sup>F]PSMA-1007-PET/ceCT Versus Na[<sup>18</sup>F]F-PET/ceCT in Prostate Cancer: Results from the PRISMA-PET Randomized Controlled Trial
Karen M Buch-Olsen, Steinbjørn Hansen, Mie H Vilstrup, et al.
Page
of 1
Search research articles
Search
Showing results (1-10 of 6) with videos related to
Sort By:
Page
of 1
EJNMMI Research
|
September 28, 2017
Group-sequential analysis may allow for early trial termination: illustration by an intra-observer repeatability study
Oke Gerke, Mie H Vilstrup, Ulrich Halekoh, et al.
Diagnostics (Basel, Switzerland)
|
December 1, 2020
Interrater Agreement and Reliability of PERCIST and Visual Assessment When Using 18F-FDG-PET/CT for Response Monitoring of Metastatic Breast Cancer
Jonas S Sørensen, Mie H Vilstrup, Jorun Holm, et al.
European Journal of Nuclear Medicine and Molecular Imaging
|
February 7, 2022
The diagnostic accuracy and clinical impact of FDG-PET/CT follow-up for patients on adjuvant immunotherapy for high-risk malignant melanoma
Jesper A S Andersen, Anders D Spatzek, Mie H Vilstrup, et al.
Journal of Nuclear Cardiology : Official Publication of the American Society of Nuclear Cardiology
|
December 6, 2013
Delayed sodium 18F-fluoride PET/CT imaging does not improve quantification of vascular calcification metabolism: results from the CAMONA study
Björn A Blomberg, Anders Thomassen, Richard A P Takx, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
November 25, 2025
Primary Staging of Intermediate- and High-Risk Prostate Cancer Using [<sup>18</sup>F]PSMA-1007 PET/CT and [<sup>18</sup>F]NaF PET/CT: A Head-to-Head Comparison of Diagnostic Accuracy, Staging, and Patient Management
Karen M Buch-Olsen, Mie H Vilstrup, Steinbjørn Hansen, et al.
European Urology Open Science
|
June 8, 2026
Progression-free Survival Following Primary Staging with [<sup>18</sup>F]PSMA-1007-PET/ceCT Versus Na[<sup>18</sup>F]F-PET/ceCT in Prostate Cancer: Results from the PRISMA-PET Randomized Controlled Trial
Karen M Buch-Olsen, Steinbjørn Hansen, Mie H Vilstrup, et al.
Page
of 1